Hole blown in Benchmark profits
Animal-focused biotech Benchmark (BMK:AIM) is one of London's largest fallers on Wednesday after warning that sales and profits will be significantly lower than expected this year. The shares have plummeted 28.7% to 79pRising...
29 April 2015
